What is ERT?

ERT is a US-based eClincial and data collection solutions provider supporting clinical trials for the pharmaceutical industry.

What does ERT do?

ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. Since 2014, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs and CROs have relied on ERT solutions in 10,000+ studies spanning more than three million patients to date. ERT identifies trial risks before they become problems, and enables customers to bring clinical treatments to patients quickly — and with confidence.

The opportunity:

  • With nearly 50 years of combined clinical, therapeutic and regulatory experience as well as technology and process-related insights, it has supported more than 13,000 clinical studies to date.
  • Proprietary, market leading technology platform to run more efficient trials and accelerate time-to-market by unlocking the hidden insights to trial data.
  • Opportunity to enhance ERT’s offering in patient support systems and post-approval solutions by leveraging existing capabilities and market position.

Why we like the investment

Opportunity to acquire an established business which is a leader in its niche market while backing a sponsor with an exceptional track record of investing in Healthcare businesses.

Investment year

2016

Head office

USA

Status

Invested

Website

https://www.ert.com/

Risk warning
Risk warning
The value of investments and the income from them can go down as well as up and you may get back less than the amount invested. The tax benefits relating to ISA investments may not be maintained. Investors should review the relevant Key Information Document (KID) brochure prior to making an investment decision.
Read the detailed risk warning 
Investor warning: Please be aware of scams that can affect investors. Read the full investor risk warning